|Articles|May 10, 2004

Investigational bulking agent for SUI provides durable efficacy at1 year

After 1 year of follow-up, women with stress urinary incontinence treatedwith an investigational bulking agent containing ethylene vinyl alcoholdissolved in a dimethyl sulfoxide carrier (EVOH/DMSO, Uryx) are demonstratingdry and improved outcomes more often than controls receiving injectablecollagen (Contigen), investigators from a multicenter study reported yesterday.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Content

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Virtual Event

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

View more
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

View more